John H Chiu, MD
Interventional Cardiology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 15
Offices
15 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chiu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A96144 · Current
Licensed to practise in California · since 2006 · expires 2028-03-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$294,519
Medicare paid this office $294,519 for 1,582 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 285 | $55,905 | $195 |
| Long return visit (40+ min) | 160 | $29,666 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 476 | $28,006 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $27,940 | $105 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $14,582 | $394 |
See all 33 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 285 | $55,905 | $195 |
| Long return visit (40+ min) | 160 | $29,666 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 476 | $28,006 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $27,940 | $105 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $14,582 | $394 |
| Critical care, first 30-74 minutes | 58 | $14,412 | $182 |
| Repair of left upper heart chamber with implant with review by radiologist | 23 | $13,471 | $586 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,014 | $148 |
| Return visit (30+ min) | 95 | $10,914 | $114 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $10,414 | $237 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 51 | $9,280 | $178 |
| Ultrasound of heart with probe in esophagus, with report | 64 | $7,177 | $92 |
| New patient visit (60+ min) | 36 | $6,768 | $188 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,405 | $534 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 362 | $4,817 | $13 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 36 | $2,883 | $78 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,845 | $158 |
| Heart muscle strain imaging | 68 | $2,618 | $38 |
| New patient visit (45+ min) | 16 | $2,515 | $157 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 133 | $2,200 | $15 |
| External shock to heart to regulate heart beat | 15 | $1,441 | $96 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 22 | $1,253 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 102 | $1,181 | $10 |
| Ultrasound of heart, follow-up | 38 | $985 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $960 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 36 | $942 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 73 | $862 | $12 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $770 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $375 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $313 | $16 |
| 3d radiographic procedure | 31 | $293 | $8 |
| Ultrasonic guidance for blood vessel access | 19 | $248 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $155 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 42 | More than 77% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,582 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 19% · Women 49% · Also on Medicaid 34% · Health risk score 1.92. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Chronic kidney disease 42% · Heart failure 41% · Atrial fibrillation 41% · Diabetes 37% · Depression 22% · COPD 21% · Cancer 19% · Stroke 18% · Dementia 12%.
The office billed $1,392,925, Medicare allowed $381,338 and paid $294,519; for 3,185 services of 75 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,582 | 3,185 | 76 | 1.92 | $1,392,925 | $294,519 |
| 2023 | 1,581 | 3,268 | 76 | 1.85 | $1,602,949 | $278,534 |
| 2022 | 1,562 | 3,374 | 77 | 1.77 | $1,550,891 | $277,580 |
| 2021 | 1,556 | 3,916 | 76 | 1.79 | $1,975,924 | $348,200 |
| 2020 | 1,699 | 3,432 | 76 | 1.88 | $1,624,481 | $269,131 |
| 2019 | 1,847 | 4,037 | 75 | 1.89 | $2,003,070 | $368,226 |
| 2018 | 1,848 | 4,699 | 76 | 1.83 | $2,220,335 | $420,988 |
| 2017 | 1,717 | 4,804 | 75 | 1.86 | $2,480,135 | $469,329 |
| 2016 | 1,207 | 3,225 | 76 | 1.85 | $1,712,803 | $330,450 |
| 2015 | 1,220 | 3,396 | 76 | 1.90 | $1,693,859 | $351,181 |
| 2014 | 1,202 | 3,108 | 76 | 1.93 | $1,855,323 | $325,500 |
| 2013 | 1,232 | 3,335 | 76 | 1.89 | $1,718,528 | $356,944 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 40 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 495 | $55,618 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 204 | $36,884 | $105 |
| Long return visit (40+ min) | 208 | $33,437 | $140 |
| Critical care, first 30-74 minutes | 62 | $16,477 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $13,375 | $154 |
| Repair of left upper heart chamber with implant with review by radiologist | 18 | $9,310 | $517 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $9,254 | $210 |
| New patient visit (60+ min) | 50 | $8,612 | $172 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,187 | $390 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 131 | $8,043 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $7,303 | $183 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,490 | $541 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,779 | $445 |
| Return visit (30+ min) | 60 | $5,678 | $93 |
| Ultrasound of heart with probe in esophagus, with report | 43 | $5,081 | $92 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,042 | $187 |
| Hospital discharge day management, more than 30 minutes | 31 | $3,190 | $103 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $2,339 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 161 | $1,993 | $12 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,974 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 304 | $1,806 | $6 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 32 | $1,710 | $53 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,600 | $94 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,491 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 104 | $1,256 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 59 | $1,217 | $21 |
| Programming of dual lead pacemaker system | 11 | $1,116 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 73 | $843 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 52 | $837 | $15 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $722 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $718 | $17 |
| Ultrasound of heart, follow-up | 27 | $639 | $22 |
| Ultrasound of heart, follow-up | 12 | $505 | $42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 53 | $252 | $5 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $221 | $16 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $192 | $4 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $163 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $127 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $116 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $101 | $3 |
2022: 43 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 518 | $60,381 | $115 |
| Long return visit (40+ min) | 186 | $31,888 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 209 | $30,812 | $90 |
| Critical care, first 30-74 minutes | 47 | $13,780 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $12,419 | $170 |
| Repair of left upper heart chamber with implant with review by radiologist | 28 | $12,136 | $433 |
| New patient visit (60+ min) | 61 | $10,395 | $170 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $9,442 | $215 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $8,061 | $202 |
| Return visit (30+ min) | 77 | $6,731 | $86 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,578 | $439 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 102 | $6,509 | $61 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $6,502 | $217 |
| Ultrasound of heart with probe in esophagus, with report | 42 | $4,878 | $92 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,597 | $95 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,236 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 165 | $2,248 | $12 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 37 | $2,124 | $57 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $2,041 | $22 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $2,018 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 245 | $1,640 | $6 |
| Heart muscle strain imaging | 35 | $1,368 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $1,345 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $1,316 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $1,225 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 103 | $1,180 | $11 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,144 | $95 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,126 | $80 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $1,087 | $49 |
| Programming of dual lead pacemaker system | 12 | $1,064 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 57 | $1,052 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 44 | $1,042 | $24 |
| External shock to heart to regulate heart beat | 12 | $964 | $80 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $963 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 74 | $904 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $663 | $60 |
| Ultrasound of heart, follow-up | 22 | $538 | $22 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 72 | $513 | $7 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 13 | $284 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $207 | $16 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 30 | $144 | $5 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $140 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $92 | $3 |
2021: 44 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 436 | $51,127 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 246 | $37,589 | $94 |
| Long return visit (40+ min) | 160 | $29,592 | $146 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 85 | $27,702 | $318 |
| Critical care, first 30-74 minutes | 56 | $19,611 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $17,394 | $183 |
| New patient visit (60+ min) | 68 | $11,990 | $176 |
| Return visit (30+ min) | 108 | $10,910 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $9,965 | $64 |
| Injection, regadenoson, 0.1 mg | 51 | $9,696 | None |
| Repair of left upper heart chamber with implant with review by radiologist | 22 | $9,513 | $432 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 45 | $8,597 | $96 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,876 | $404 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,540 | $222 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,391 | $225 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 23 | $4,946 | $23 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,579 | $199 |
| Ultrasound of heart with probe in esophagus, with report | 35 | $3,566 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 55 | $3,395 | $62 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,254 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 195 | $2,754 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $2,602 | $26 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $1,910 | $83 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $1,672 | $27 |
| External shock to heart to regulate heart beat | 15 | $1,552 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 207 | $1,470 | $7 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 23 | $1,414 | $61 |
| Programming of dual lead pacemaker system | 16 | $1,342 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,271 | $67 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $1,163 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 60 | $1,136 | $19 |
| Heart muscle strain imaging | 25 | $1,056 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 62 | $788 | $13 |
| Ultrasound of both sides of head and neck blood flow | 16 | $735 | $46 |
| Ultrasound of heart, follow-up | 28 | $673 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $643 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $486 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $485 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $434 | $22 |
| Injection, aminophyllin, up to 250 mg | 51 | $372 | None |
| Ultrasound of heart blood flow, valves and chambers | 21 | $348 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $99 | $6 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $63 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $52 | $3 |
2020: 41 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 351 | $41,105 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 248 | $37,584 | $95 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $21,661 | $217 |
| Critical care, first 30-74 minutes | 50 | $14,039 | $201 |
| Return visit (30+ min) | 142 | $13,771 | $85 |
| Long return visit (40+ min) | 105 | $13,737 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $12,692 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $10,589 | $183 |
| New patient visit (60+ min) | 44 | $7,372 | $168 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 36 | $7,060 | $98 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $6,408 | $194 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,243 | $446 |
| Injection, regadenoson, 0.1 mg | 33 | $6,200 | None |
| Ultrasound of both sides of head and neck blood flow | 30 | $3,996 | $133 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,558 | $237 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,309 | $100 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 443 | $2,968 | $6 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,627 | $202 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $2,598 | $25 |
| Short return visit (20+ min) | 41 | $2,279 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 37 | $2,226 | $60 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $2,033 | $169 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,726 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 80 | $1,630 | $20 |
| New patient visit (45+ min) | 11 | $1,571 | $143 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $1,391 | $27 |
| Programming of dual lead pacemaker system | 19 | $1,386 | $63 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,280 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 95 | $1,252 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 80 | $1,093 | $14 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $939 | $63 |
| Ultrasound of heart, follow-up | 28 | $811 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $592 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $548 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $539 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 27 | $532 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $359 | $11 |
| Injection, aminophyllin, up to 250 mg | 32 | $225 | None |
| Ultrasound of heart blood flow, valves and chambers | 11 | $170 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $149 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $74 | $3 |
2019: 41 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 292 | $42,693 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 131 | $42,653 | $326 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | $35,549 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 308 | $20,869 | $66 |
| Long return visit (40+ min) | 142 | $18,201 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $17,818 | $178 |
| Ultrasound of both sides of head and neck blood flow | 88 | $15,662 | $178 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 79 | $15,298 | $97 |
| Return visit (30+ min) | 144 | $12,651 | $83 |
| Injection, regadenoson, 0.1 mg | 68 | $12,366 | None |
| Critical care, first 30-74 minutes | 45 | $11,475 | $194 |
| New patient visit (60+ min) | 63 | $10,333 | $164 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $9,578 | $218 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 15 | $8,410 | $561 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $7,697 | $428 |
| Ultrasound of leg arteries or artery grafts | 27 | $5,735 | $212 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,371 | $413 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 84 | $5,059 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $4,999 | $192 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,514 | $215 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 258 | $4,208 | $14 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $2,608 | $217 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 323 | $2,428 | $7 |
| New patient visit (45+ min) | 19 | $2,334 | $123 |
| Programming of dual lead pacemaker system | 25 | $2,309 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $2,093 | $100 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 14 | $1,648 | $118 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,382 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 60 | $1,152 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 41 | $1,110 | $26 |
| Hospital discharge day management, more than 30 minutes | 11 | $984 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 70 | $927 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $918 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $783 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $677 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $452 | $11 |
| Ultrasound of heart, follow-up | 18 | $423 | $24 |
| Injection, aminophyllin, up to 250 mg | 65 | $376 | None |
| Ultrasound of heart blood flow, valves and chambers | 19 | $354 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $107 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $62 | $3 |
2018: 39 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 203 | $80,537 | $397 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $44,371 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 268 | $35,778 | $89 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 165 | $30,316 | $92 |
| Injection, regadenoson, 0.1 mg | 153 | $26,917 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $16,778 | $63 |
| Long return visit (40+ min) | 137 | $16,755 | $110 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $13,767 | $382 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $12,785 | $175 |
| New patient visit (60+ min) | 78 | $12,441 | $160 |
| Critical care, first 30-74 minutes | 43 | $11,721 | $186 |
| Return visit (30+ min) | 131 | $10,797 | $81 |
| Ultrasound of both sides of head and neck blood flow | 59 | $10,266 | $174 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 169 | $9,698 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $9,337 | $203 |
| Ultrasound of leg arteries or artery grafts | 25 | $6,186 | $247 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,793 | $215 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $4,209 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 240 | $3,769 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,466 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 317 | $2,187 | $7 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $2,089 | $174 |
| Programming of dual lead pacemaker system | 25 | $1,983 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,443 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 72 | $1,391 | $19 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,369 | $91 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 22 | $1,303 | $59 |
| New patient visit (45+ min) | 11 | $1,249 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 67 | $976 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 72 | $945 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 43 | $876 | $20 |
| Injection, aminophyllin, up to 250 mg | 106 | $540 | None |
| Ultrasound of heart, follow-up | 20 | $492 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $469 | $16 |
| Ultrasonic guidance for blood vessel access | 35 | $407 | $12 |
| Ultrasonic guidance for blood vessel access | 34 | $395 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $127 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $127 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $75 | $3 |
2017: 41 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 204 | $93,069 | $454 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 312 | $53,858 | $171 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 202 | $38,455 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 260 | $38,329 | $90 |
| Injection, regadenoson, 0.1 mg | 179 | $30,806 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 72 | $17,501 | $243 |
| Long return visit (40+ min) | 129 | $17,047 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $15,644 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,586 | $173 |
| Ultrasound of both sides of head and neck blood flow | 81 | $14,320 | $173 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 196 | $12,401 | $63 |
| New patient visit (60+ min) | 73 | $11,973 | $164 |
| Return visit (30+ min) | 126 | $10,239 | $79 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $9,270 | $357 |
| Critical care, first 30-74 minutes | 30 | $6,579 | $188 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,970 | $398 |
| Ultrasound of leg arteries or artery grafts | 25 | $5,898 | $227 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 227 | $3,524 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,319 | $175 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,028 | $189 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $2,757 | $230 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,955 | $150 |
| Programming of dual lead pacemaker system | 23 | $1,861 | $47 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,832 | $92 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $1,758 | $135 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 106 | $1,553 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 72 | $1,458 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,276 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,202 | $63 |
| New patient visit (45+ min) | 11 | $1,164 | $106 |
| Injection, aminophyllin, up to 250 mg | 178 | $1,150 | None |
| Hospital discharge day management, 30 minutes or less | 13 | $839 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $700 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $554 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 25 | $490 | $20 |
| Ultrasound of heart, follow-up | 15 | $364 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $355 | $13 |
| Ultrasonic guidance for blood vessel access | 22 | $301 | $13 |
| Ultrasonic guidance for blood vessel access | 19 | $263 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $110 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $76 | $3 |
2016: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 115 | $52,389 | $456 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $34,068 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 233 | $32,249 | $87 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 118 | $22,125 | $95 |
| Injection, regadenoson, 0.1 mg | 97 | $16,397 | None |
| Long return visit (40+ min) | 118 | $13,979 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | $12,456 | $54 |
| New patient visit (60+ min) | 71 | $12,275 | $173 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,245 | $170 |
| Ultrasound of both sides of head and neck blood flow | 62 | $10,309 | $164 |
| Return visit (30+ min) | 112 | $9,205 | $77 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,541 | $397 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 120 | $7,142 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $6,647 | $214 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $5,815 | $201 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,790 | $211 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 180 | $2,924 | $14 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 19 | $2,862 | $143 |
| Ultrasound of leg arteries or artery grafts | 23 | $2,537 | $110 |
| Critical care, first 30-74 minutes | 11 | $2,411 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,127 | $61 |
| New patient visit (45+ min) | 16 | $2,082 | $130 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,910 | $96 |
| Programming of dual lead pacemaker system | 24 | $1,460 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 54 | $800 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $776 | $24 |
| Injection, aminophyllin, up to 250 mg | 96 | $638 | None |
| Ultrasound of heart, follow-up | 15 | $395 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $346 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $112 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $71 | $3 |
2015: 35 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 112 | $51,659 | $461 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 263 | $41,475 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $38,163 | $207 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 113 | $29,729 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $20,057 | $174 |
| Injection, regadenoson, 0.1 mg | 101 | $16,614 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 252 | $14,020 | $55 |
| Long return visit (40+ min) | 94 | $12,346 | $122 |
| Return visit (30+ min) | 113 | $11,389 | $85 |
| Ultrasound of both sides of head and neck blood flow | 63 | $11,366 | $180 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $11,275 | $389 |
| New patient visit (60+ min) | 56 | $9,459 | $169 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $9,354 | $240 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 117 | $7,082 | $61 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,098 | $554 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,445 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $3,557 | $62 |
| Ultrasound of leg arteries or artery grafts | 17 | $3,458 | $203 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 187 | $3,086 | $15 |
| New patient visit (45+ min) | 21 | $2,893 | $138 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,668 | $148 |
| Critical care, first 30-74 minutes | 11 | $2,658 | $190 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,651 | $166 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,863 | $103 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,862 | $56 |
| Programming of dual lead pacemaker system | 16 | $1,615 | $47 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $1,043 | $25 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,013 | $92 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 37 | $975 | $26 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $820 | $68 |
| Ultrasound of heart, follow-up | 23 | $539 | $22 |
| Injection, aminophyllin, up to 250 mg | 97 | $349 | None |
| Ultrasound of heart blood flow, valves and chambers | 21 | $337 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 24 | $160 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $135 | $3 |
2014: 34 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 106 | $49,076 | $463 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 222 | $31,295 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 152 | $30,749 | $202 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 106 | $27,956 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 132 | $23,635 | $174 |
| Return visit (30+ min) | 125 | $18,294 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 318 | $17,644 | $55 |
| Injection, regadenoson, 0.1 mg | 92 | $15,264 | None |
| Ultrasound of both sides of head and neck blood flow | 65 | $10,514 | $162 |
| Long return visit (40+ min) | 65 | $8,768 | $115 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $8,663 | $413 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $8,394 | $247 |
| New patient visit (60+ min) | 48 | $8,333 | $174 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 113 | $6,831 | $60 |
| Ultrasound of leg arteries or artery grafts | 24 | $5,316 | $222 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,855 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $4,739 | $61 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $3,593 | $189 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $2,911 | $265 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 138 | $2,176 | $14 |
| Programming of dual lead pacemaker system | 23 | $1,638 | $44 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $1,594 | $72 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,581 | $93 |
| Ultrasound study of arm and leg arteries | 21 | $1,343 | $64 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,271 | $85 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 34 | $1,002 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $948 | $25 |
| Short return visit (20+ min) | 14 | $912 | $65 |
| Ultrasound of heart, follow-up | 20 | $468 | $22 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $403 | $34 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $328 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $134 | $6 |
| Injection, aminophyllin, up to 250 mg | 59 | $126 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 40 | $121 | $3 |
2013: 33 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 130 | $62,385 | $480 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 135 | $35,285 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 204 | $34,563 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 204 | $31,029 | $87 |
| Injection, regadenoson, 0.1 mg | 113 | $18,788 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $16,837 | $170 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 301 | $16,309 | $53 |
| Return visit (30+ min) | 105 | $15,554 | $93 |
| Long return visit (40+ min) | 98 | $14,567 | $117 |
| Ultrasound of both sides of head and neck blood flow | 85 | $12,689 | $149 |
| New patient visit (60+ min) | 66 | $11,468 | $174 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 45 | $9,610 | $209 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 135 | $8,522 | $63 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,368 | $433 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $4,616 | $178 |
| Ultrasound of leg arteries or artery grafts | 23 | $4,256 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $4,169 | $60 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 16 | $3,619 | $226 |
| Hospital discharge day management, more than 30 minutes | 37 | $3,297 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 159 | $2,990 | $17 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $2,164 | $166 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,851 | $88 |
| Programming of dual lead pacemaker system | 19 | $1,344 | $45 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $1,171 | $69 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 46 | $1,051 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $916 | $19 |
| Ultrasound study of arm and leg arteries | 13 | $854 | $66 |
| Hospital observation care on day of discharge | 11 | $651 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $491 | $33 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $438 | $16 |
| Ultrasound of heart, follow-up | 12 | $237 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $121 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $67 | $6 |
Medicaid work
$12,423 in 2024
Medicaid paid $12,423 for 569 billed services this clinician did in 2024, up to 55 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 505 | $11,076 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 37 | $1,318 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $21 |
| CARDIOVASCULAR STRESS TEST | 13 | $9 |
| 2024 | 569 | 4 | 55 | $12,423 |
| 2023 | 709 | 5 | 75 | $20,635 |
| 2022 | 448 | 4 | 47 | $11,884 |
| 2021 | 494 | 4 | 48 | $14,956 |
| 2020 | 344 | 2 | 53 | $12,807 |
| 2019 | 506 | 5 | 36 | $15,286 |
| 2018 | 731 | 9 | 43 | $22,688 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 476 | $13,397 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 188 | $7,089 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $75 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 12 | $43 |
| CARDIOVASCULAR STRESS TEST | 19 | $32 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 374 | $10,383 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 45 | $1,378 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 17 | $117 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 12 | $7 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 340 | $9,224 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 116 | $4,900 |
| Return visit (30+ min) | 14 | $711 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 24 | $122 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 278 | $9,503 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 66 | $3,303 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 282 | $9,936 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 123 | $4,262 |
| Return visit (30+ min) | 18 | $739 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 45 | $231 |
| CARDIOVASCULAR STRESS TEST | 38 | $119 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 300 | $8,441 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 108 | $4,792 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 46 | $3,887 |
| Injection, regadenoson, 0.1 mg | 44 | $2,888 |
| Tc99m sestamibi | 82 | $1,688 |
| CARDIOVASCULAR STRESS TEST | 98 | $850 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $131 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 12 | $6 |
| Injection, aminophyllin, up to 250 mg | 13 | $4 |
Drugs they prescribed that Part D paid
$382,284
Pharmacies billed $382,284 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,694) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
1,346 generic and 348 brand-name prescriptions · $382,284 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 111 | $114,809 | $1,034 |
| Xarelto | 78 | $95,482 | $1,224 |
| Farxiga | 46 | $42,961 | $934 |
| Entresto | 27 | $42,360 | $1,569 |
| Repatha Sureclick | 19 | $16,349 | $860 |
See all 25 drugs
| Eliquis | 111 | $114,809 | $1,034 |
| Xarelto | 78 | $95,482 | $1,224 |
| Farxiga | 46 | $42,961 | $934 |
| Entresto | 27 | $42,360 | $1,569 |
| Repatha Sureclick | 19 | $16,349 | $860 |
| Atorvastatin | 271 | $4,021 | $15 |
| Prasugrel | 23 | $2,002 | $87 |
| Metoprolol | 135 | $1,907 | $14 |
| Rosuvastatin | 52 | $1,737 | $33 |
| Clopidogrel | 130 | $1,638 | $13 |
| Carvedilol | 104 | $1,155 | $11 |
| Nitroglycerin | 38 | $1,078 | $28 |
| Losartan | 73 | $917 | $13 |
| Ezetimibe | 18 | $755 | $42 |
| Diltiazem 24hr Er (Cd) | 14 | $670 | $48 |
| Spironolactone | 49 | $666 | $14 |
| Lisinopril | 71 | $666 | $9 |
| Amlodipine Besylate | 46 | $626 | $14 |
| Metoprolol | 68 | $506 | $7 |
| Isosorbide Mononitrate Er | 28 | $416 | $15 |
| Digoxin | 11 | $388 | $35 |
| Nifedipine Er | 11 | $374 | $34 |
| Potassium Chloride | 16 | $342 | $21 |
| Furosemide | 44 | $288 | $7 |
| Hydrochlorothiazide | 25 | $98 | $4 |
Year by year
| 2024 | 1,694 | 321 | 0% (0) | 21% | $382,284 |
| 2023 | 1,791 | 349 | 0% (0) | 18% | $381,102 |
| 2022 | 1,802 | 340 | 0% (0) | 19% | $365,342 |
| 2021 | 1,766 | 320 | 0% (0) | 17% | $312,472 |
| 2020 | 1,541 | 292 | 0% (0) | 18% | $249,182 |
| 2019 | 1,542 | 296 | 0% (0) | 19% | $204,750 |
| 2018 | 1,470 | 249 | 0% (0) | 19% | $146,947 |
| 2017 | 1,447 | 217 | 0% (0) | 20% | $121,272 |
| 2016 | 1,415 | 210 | 0% (0) | 20% | $96,156 |
| 2015 | 1,418 | 172 | 0% (0) | 20% | $96,026 |
| 2014 | 1,399 | 169 | 0% (0) | 23% | $87,503 |
| 2013 | 1,428 | 191 | 0% (0) | None | $96,042 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Xarelto | 90 | $129,922 | $1,444 |
| Eliquis | 92 | $97,163 | $1,056 |
| Entresto | 32 | $39,895 | $1,247 |
| Farxiga | 36 | $32,700 | $908 |
| Atorvastatin | 294 | $6,036 | $21 |
| Vascepa | 12 | $4,674 | $390 |
| Metoprolol | 145 | $3,176 | $22 |
| Prasugrel | 17 | $2,858 | $168 |
| Rosuvastatin | 46 | $2,364 | $51 |
| Carvedilol | 153 | $2,172 | $14 |
| Isosorbide Mononitrate Er | 47 | $2,120 | $45 |
| Lisinopril | 80 | $1,335 | $17 |
| Losartan | 67 | $1,135 | $17 |
| Clopidogrel | 64 | $1,002 | $16 |
| Amlodipine Besylate | 67 | $897 | $13 |
| Diltiazem 24hr Er (Cd) | 17 | $866 | $51 |
| Digoxin | 16 | $858 | $54 |
| Nitroglycerin | 25 | $811 | $32 |
| Metoprolol | 97 | $759 | $8 |
| Spironolactone | 51 | $589 | $12 |
| Enalapril Maleate | 17 | $566 | $33 |
| Furosemide | 50 | $550 | $11 |
| Potassium Chloride | 16 | $510 | $32 |
| Hydralazine | 12 | $400 | $33 |
| Amiodarone | 20 | $368 | $18 |
| Hydrochlorothiazide | 24 | $82 | $3 |
2022: 25 drugs
| Xarelto | 119 | $141,742 | $1,191 |
| Eliquis | 84 | $101,086 | $1,203 |
| Entresto | 26 | $27,579 | $1,061 |
| Brilinta | 13 | $5,936 | $457 |
| Atorvastatin | 298 | $5,017 | $17 |
| Metoprolol | 179 | $3,575 | $20 |
| Ezetimibe | 19 | $2,532 | $133 |
| Carvedilol | 154 | $2,065 | $13 |
| Losartan | 60 | $1,336 | $22 |
| Clopidogrel | 90 | $1,313 | $15 |
| Isosorbide Mononitrate Er | 40 | $1,166 | $29 |
| Diltiazem 24hr Er (Cd) | 34 | $830 | $24 |
| Digoxin | 25 | $777 | $31 |
| Lisinopril | 86 | $767 | $9 |
| Potassium Chloride | 13 | $647 | $50 |
| Metoprolol | 84 | $598 | $7 |
| Rosuvastatin | 26 | $540 | $21 |
| Nitroglycerin | 23 | $475 | $21 |
| Enalapril Maleate | 19 | $452 | $24 |
| Spironolactone | 31 | $431 | $14 |
| Amlodipine Besylate | 65 | $422 | $6 |
| Amiodarone | 12 | $418 | $35 |
| Furosemide | 50 | $402 | $8 |
| Hydralazine | 12 | $171 | $14 |
| Hydrochlorothiazide | 29 | $102 | $4 |
2021: 27 drugs
| Xarelto | 129 | $140,719 | $1,091 |
| Eliquis | 76 | $72,564 | $955 |
| Repatha Sureclick | 11 | $10,424 | $948 |
| Livalo | 11 | $8,194 | $745 |
| Atorvastatin | 302 | $5,374 | $18 |
| Prasugrel | 11 | $3,433 | $312 |
| Metoprolol | 147 | $3,145 | $21 |
| Icosapent Ethyl | 16 | $2,838 | $177 |
| Carvedilol | 105 | $1,636 | $16 |
| Rosuvastatin | 41 | $1,587 | $39 |
| Isosorbide Mononitrate Er | 63 | $1,551 | $25 |
| Losartan | 74 | $1,397 | $19 |
| Clopidogrel | 99 | $1,133 | $11 |
| Digoxin | 31 | $1,069 | $34 |
| Diltiazem 24hr Er (Cd) | 16 | $888 | $56 |
| Amiodarone | 12 | $817 | $68 |
| Lisinopril | 92 | $675 | $7 |
| Verapamil Er | 11 | $633 | $58 |
| Hydralazine | 31 | $535 | $17 |
| Metoprolol | 76 | $468 | $6 |
| Spironolactone | 30 | $446 | $15 |
| Nitroglycerin | 17 | $444 | $26 |
| Enalapril Maleate | 16 | $350 | $22 |
| Atenolol | 16 | $272 | $17 |
| Furosemide | 37 | $260 | $7 |
| Amlodipine Besylate | 66 | $256 | $4 |
| Hydrochlorothiazide | 34 | $128 | $4 |
2020: 24 drugs
| Xarelto | 99 | $102,936 | $1,040 |
| Eliquis | 66 | $58,224 | $882 |
| Pradaxa | 12 | $13,730 | $1,144 |
| Atorvastatin | 251 | $4,824 | $19 |
| Prasugrel | 17 | $4,629 | $272 |
| Metoprolol | 149 | $3,799 | $25 |
| Ranolazine Er | 13 | $2,654 | $204 |
| Rosuvastatin | 35 | $1,682 | $48 |
| Diltiazem 24hr Er (Cd) | 30 | $1,372 | $46 |
| Isosorbide Mononitrate Er | 44 | $1,351 | $31 |
| Carvedilol | 120 | $1,273 | $11 |
| Digoxin | 28 | $1,089 | $39 |
| Nitroglycerin | 33 | $891 | $27 |
| Clopidogrel | 64 | $881 | $14 |
| Losartan | 43 | $842 | $20 |
| Metoprolol | 77 | $547 | $7 |
| Lisinopril | 80 | $473 | $6 |
| Furosemide | 52 | $429 | $8 |
| Ramipril | 13 | $425 | $33 |
| Warfarin | 12 | $342 | $29 |
| Spironolactone | 22 | $254 | $12 |
| Amlodipine Besylate | 50 | $245 | $5 |
| Verapamil Er | 13 | $244 | $19 |
| Hydrochlorothiazide | 16 | $32 | $2 |
2019: 25 drugs
| Xarelto | 110 | $84,452 | $768 |
| Eliquis | 65 | $47,074 | $724 |
| Pradaxa | 23 | $16,938 | $736 |
| Atorvastatin | 271 | $5,244 | $19 |
| Metoprolol | 119 | $3,482 | $29 |
| Crestor | 11 | $2,769 | $252 |
| Rosuvastatin | 45 | $2,025 | $45 |
| Prasugrel | 11 | $1,721 | $156 |
| Carvedilol | 108 | $1,576 | $15 |
| Isosorbide Dinitrate | 13 | $1,563 | $120 |
| Clopidogrel | 108 | $1,465 | $14 |
| Isosorbide Mononitrate Er | 41 | $1,409 | $34 |
| Hydralazine | 23 | $947 | $41 |
| Nitroglycerin | 29 | $811 | $28 |
| Potassium Chloride | 15 | $801 | $53 |
| Amlodipine Besylate | 78 | $680 | $9 |
| Lisinopril | 71 | $652 | $9 |
| Digox | 12 | $649 | $54 |
| Losartan | 42 | $624 | $15 |
| Metoprolol | 69 | $606 | $9 |
| Ramipril | 11 | $565 | $51 |
| Furosemide | 48 | $510 | $11 |
| Warfarin | 15 | $505 | $34 |
| Spironolactone | 13 | $193 | $15 |
| Simvastatin | 15 | $139 | $9 |
2018: 23 drugs
| Xarelto | 132 | $81,814 | $620 |
| Eliquis | 34 | $13,994 | $412 |
| Atorvastatin | 245 | $4,966 | $20 |
| Crestor | 12 | $3,040 | $253 |
| Prasugrel | 16 | $2,797 | $175 |
| Metoprolol | 87 | $2,574 | $30 |
| Rosuvastatin | 43 | $1,609 | $37 |
| Isosorbide Mononitrate Er | 44 | $1,384 | $31 |
| Potassium Chloride | 37 | $1,105 | $30 |
| Clopidogrel | 86 | $1,034 | $12 |
| Carvedilol | 121 | $1,007 | $8 |
| Nitroglycerin | 36 | $941 | $26 |
| Warfarin | 28 | $632 | $23 |
| Metoprolol | 80 | $617 | $8 |
| Amlodipine Besylate | 78 | $415 | $5 |
| Losartan | 36 | $407 | $11 |
| Hydralazine | 20 | $403 | $20 |
| Lisinopril | 48 | $378 | $8 |
| Simvastatin | 18 | $224 | $12 |
| Spironolactone | 20 | $219 | $11 |
| Furosemide | 53 | $172 | $3 |
| Losartan-Hydrochlorothiazide | 11 | $70 | $6 |
| Hydrochlorothiazide | 16 | $55 | $3 |
2017: 24 drugs
| Xarelto | 111 | $55,565 | $501 |
| Eliquis | 16 | $6,223 | $389 |
| Atorvastatin | 248 | $4,740 | $19 |
| Crestor | 12 | $2,864 | $239 |
| Metoprolol | 97 | $2,802 | $29 |
| Rosuvastatin | 34 | $2,607 | $77 |
| Potassium Chloride | 39 | $1,402 | $36 |
| Isosorbide Mononitrate Er | 46 | $1,160 | $25 |
| Digox | 12 | $1,102 | $92 |
| Carvedilol | 136 | $880 | $6 |
| Hydralazine | 30 | $769 | $26 |
| Cartia Xt | 17 | $628 | $37 |
| Nitroglycerin | 16 | $578 | $36 |
| Metoprolol | 66 | $550 | $8 |
| Warfarin | 35 | $540 | $15 |
| Clopidogrel | 59 | $454 | $8 |
| Amlodipine Besylate | 82 | $454 | $6 |
| Lisinopril | 77 | $441 | $6 |
| Losartan | 40 | $212 | $5 |
| Spironolactone | 20 | $205 | $10 |
| Furosemide | 32 | $161 | $5 |
| Simvastatin | 14 | $160 | $11 |
| Pravastatin | 12 | $116 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $46 | $3 |
2016: 30 drugs
| Xarelto | 46 | $25,060 | $545 |
| Pradaxa | 25 | $14,055 | $562 |
| Crestor | 24 | $9,198 | $383 |
| Brilinta | 20 | $8,410 | $420 |
| Eliquis | 14 | $6,345 | $453 |
| Zetia | 15 | $6,164 | $411 |
| Atorvastatin | 310 | $5,721 | $18 |
| Metoprolol | 94 | $1,969 | $21 |
| Rosuvastatin | 13 | $958 | $74 |
| Carvedilol | 115 | $808 | $7 |
| Clopidogrel | 69 | $805 | $12 |
| Isosorbide Mononitrate Er | 41 | $791 | $19 |
| Metoprolol | 98 | $784 | $8 |
| Potassium Chloride | 32 | $722 | $23 |
| Digox | 15 | $578 | $39 |
| Bumetanide | 18 | $511 | $28 |
| Warfarin | 31 | $426 | $14 |
| Verapamil Sr | 12 | $425 | $35 |
| Diltiazem 24hr Er | 17 | $405 | $24 |
| Nitrostat | 14 | $392 | $28 |
| Hydralazine | 20 | $384 | $19 |
| Amlodipine Besylate | 65 | $376 | $6 |
| Spironolactone | 18 | $261 | $15 |
| Losartan | 32 | $248 | $8 |
| Lisinopril | 65 | $234 | $4 |
| Valsartan | 12 | $233 | $19 |
| Furosemide | 36 | $178 | $5 |
| Amiodarone | 12 | $103 | $9 |
| Simvastatin | 13 | $77 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $26 | $2 |
2015: 28 drugs
| Xarelto | 65 | $31,682 | $487 |
| Pradaxa | 29 | $14,809 | $511 |
| Crestor | 32 | $11,301 | $353 |
| Atorvastatin | 279 | $5,497 | $20 |
| Eliquis | 11 | $3,698 | $336 |
| Propafenone Hcl Er | 11 | $3,053 | $278 |
| Livalo | 11 | $2,022 | $184 |
| Metoprolol | 66 | $1,863 | $28 |
| Warfarin | 49 | $938 | $19 |
| Carvedilol | 128 | $776 | $6 |
| Clopidogrel | 80 | $752 | $9 |
| Potassium Chloride | 21 | $717 | $34 |
| Metoprolol | 90 | $635 | $7 |
| Digox | 16 | $588 | $37 |
| Isosorbide Mononitrate Er | 41 | $479 | $12 |
| Amiodarone | 14 | $471 | $34 |
| Lisinopril | 104 | $389 | $4 |
| Bumetanide | 14 | $385 | $28 |
| Diltiazem 24hr Er | 11 | $296 | $27 |
| Losartan | 28 | $228 | $8 |
| Spironolactone | 37 | $221 | $6 |
| Amlodipine Besylate | 47 | $193 | $4 |
| Furosemide | 45 | $141 | $3 |
| Minoxidil | 12 | $121 | $10 |
| Triamterene-Hydrochlorothiazid | 19 | $102 | $5 |
| Hydralazine | 14 | $99 | $7 |
| Simvastatin | 15 | $73 | $5 |
| Atenolol | 12 | $49 | $4 |
2014: 26 drugs
| Xarelto | 61 | $23,598 | $387 |
| Crestor | 38 | $13,122 | $345 |
| Pradaxa | 26 | $11,449 | $440 |
| Atorvastatin | 232 | $4,063 | $18 |
| Effient | 13 | $3,805 | $293 |
| Metoprolol | 92 | $3,596 | $39 |
| Brilinta | 11 | $2,794 | $254 |
| Livalo | 13 | $2,114 | $163 |
| Carvedilol | 122 | $1,147 | $9 |
| Clopidogrel | 84 | $1,139 | $14 |
| Potassium Chloride | 31 | $1,041 | $34 |
| Warfarin | 64 | $902 | $14 |
| Isosorbide Mononitrate Er | 45 | $886 | $20 |
| Ramipril | 12 | $434 | $36 |
| Metoprolol | 70 | $407 | $6 |
| Amiodarone | 12 | $391 | $33 |
| Lisinopril | 98 | $378 | $4 |
| Amlodipine Besylate | 57 | $329 | $6 |
| Furosemide | 52 | $195 | $4 |
| Simvastatin | 22 | $181 | $8 |
| Losartan | 19 | $156 | $8 |
| Triamterene-Hydrochlorothiazid | 26 | $146 | $6 |
| Nitrostat | 11 | $139 | $13 |
| Bumetanide | 11 | $138 | $13 |
| Spironolactone | 26 | $125 | $5 |
| Atenolol | 12 | $117 | $10 |
2013: 25 drugs
| Xarelto | 72 | $24,964 | $347 |
| Pradaxa | 31 | $11,015 | $355 |
| Brilinta | 36 | $9,655 | $268 |
| Crestor | 42 | $8,783 | $209 |
| Effient | 17 | $6,162 | $362 |
| Atorvastatin | 162 | $4,640 | $29 |
| Metoprolol | 90 | $2,881 | $32 |
| Clopidogrel | 114 | $2,600 | $23 |
| Fenofibrate | 12 | $1,408 | $117 |
| Carvedilol | 107 | $1,257 | $12 |
| Potassium Chloride | 33 | $1,227 | $37 |
| Isosorbide Mononitrate Er | 52 | $1,015 | $20 |
| Warfarin | 85 | $906 | $11 |
| Hydralazine | 25 | $820 | $33 |
| Amiodarone | 20 | $688 | $34 |
| Metoprolol | 79 | $671 | $8 |
| Lisinopril | 99 | $538 | $5 |
| Simvastatin | 51 | $469 | $9 |
| Amlodipine Besylate | 42 | $292 | $7 |
| Nitrostat | 22 | $239 | $11 |
| Atenolol | 25 | $238 | $10 |
| Digox | 22 | $199 | $9 |
| Furosemide | 38 | $158 | $4 |
| Losartan | 11 | $158 | $14 |
| Triamterene-Hctz | 12 | $79 | $7 |
Money from drug and device companies
$80 in 2025
| 2025 | 3 | 4 | None | $80 |
| 2024 | 2 | 2 | None | $53 |
| 2023 | 1 | 1 | None | $23 |
| 2022 | 2 | 7 | None | $243 |
| 2021 | 3 | 5 | None | $64 |
| 2020 | 1 | 1 | None | $30 |
| 2019 | 3 | 4 | None | $139 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Access System | $40 | 2 payments
|
| Abbott Laboratories | Amplatzer Amulet | $25 | 1 payment
|
| Pfizer | Eliquis | $15 | 1 payment
|
See all 4 published payments
| Boston Scientific | Meals · 2025-12-19 | Watchman Access System | $23 |
| Boston Scientific | Meals · 2025-10-29 | Watchman Flx | $18 |
| Abbott Laboratories | Meals · 2025-03-13 | Amplatzer Amulet | $25 |
| Pfizer | Meals · 2025-03-04 | Eliquis | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $53
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $38 | 1 payment
|
| Boston Scientific | Rotapro | $16 | 1 payment
|
2023: $23
| Boston Scientific | Watchman Access System | $23 | 1 payment
|
2022: $243
| Abbott Laboratories | Amplatzer Amulet | $200 | 4 payments
|
| Chiesi USA | Kengreal | $44 | 3 payments
|
2021: $64
| Shockwave Medical | Vascular Lithotripsy | $29 | 2 payments
|
| Medtronic | Telescope | $24 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $11 | 1 payment
|
2020: $30
| Boston Scientific | Watchman | $30 | 1 payment
|
2019: $139
| Boston Scientific | Rotablator | $90 | 1 payment
|
| Abbott Laboratories | Hi-Torque Whisper Guide Wire | $38 | 2 payments
|
| Medtronic Vascular | Resolute | $11 | 1 payment
|
Professional record
- NPI
- 1629007000
- Licence
- CA A96144, OH 35081561California A96144: Current · expires 2028-03-31
- Trained
- Washington University School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 365 Hawthorne Ave Ste 201, Oakland, CA, 94609
- NPI first listed
- 2006-06-30
- NPI last updated
- 2026-01-07
- NPI record certified
- 2026-01-07
This is when the NPI record was last certified, not a medical board exam.